Literature DB >> 28567476

Malignization of a vestibular schwannoma 13 years after radiation therapy.

S Simmermacher1, D Vordermark2, T Kegel3, C Strauss4.   

Abstract

This article presents a case of malignant transformation of vestibular schwannoma 13 years after stereotactic radiation therapy, which lead to an acute life-threatening condition. Although the observation is currently only based on case reports, an increasing number of these support the hypothesis that there is a relevant risk of malignant transformation in the long-term course of previously irradiated vestibular schwannomas. Therefore, long-term MRI follow-up should be considered.

Entities:  

Keywords:  Malignant peripheral nerve sheath tumor; Malignant transformation; Stereotactic radiotherapy; Vestibular schwannoma

Mesh：

Year:  2017        PMID： 28567476     DOI： 10.1007/s00106-017-0362-8

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


  13 in total

Review 1.  What is the risk of malignant transformation of vestibular schwannoma following radiosurgery?

Authors:  Elizabeth A Nicolli; Michael Ruckenstein
Journal:  Laryngoscope       Date:  2015-02-13       Impact factor: 3.325

2.  Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.

Authors:  Stephanie E Combs; Christina Engelhard; Christine Kopp; Nicole Wiedenmann; Oliver Schramm; Vesna Prokic; Jürgen Debus; Michael Molls; Anca-Ligia Grosu
Journal:  Radiother Oncol       Date:  2015-02-20       Impact factor: 6.280

Review 3.  Malignant transformation in vestibular schwannoma: report of a single case, literature search, and debate.

Authors:  Charalampos Seferis; Michael Torrens; Chryssa Paraskevopoulou; Georgios Psichidis
Journal:  J Neurosurg       Date:  2014-12       Impact factor: 5.115

4.  The Changing Landscape of Vestibular Schwannoma Management in the United States--A Shift Toward Conservatism.

Authors:  Matthew L Carlson; Elizabeth B Habermann; Amy E Wagie; Colin L Driscoll; Jamie J Van Gompel; Jeffrey T Jacob; Michael J Link
Journal:  Otolaryngol Head Neck Surg       Date:  2015-06-30       Impact factor: 3.497

5.  [Imaging of acoustic neuroma (vestibular schwannoma). Breakthrough or dilemma?].

Authors:  E Hofmann; L Choné
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

6.  Current epidemiology and management trends in acoustic neuroma.

Authors:  Thomas J Gal; Jennifer Shinn; Bin Huang
Journal:  Otolaryngol Head Neck Surg       Date:  2010-05       Impact factor: 3.497

7.  Late malignant transformation of vestibular schwannoma in the absence of irradiation: case report.

Authors:  Asma Bashir; Lars Poulsgaard; Helle Broholm; Kåre Fugleholm
Journal:  J Neurosurg       Date:  2015-11-27       Impact factor: 5.115

8.  Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases.

Authors:  Bernd W Scheithauer; Sibel Erdogan; Fausto J Rodriguez; Peter C Burger; James M Woodruff; Johan M Kros; Murat Gokden; Robert J Spinner
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

9.  Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).

Authors:  T Valentin; A Le Cesne; I Ray-Coquard; A Italiano; G Decanter; E Bompas; N Isambert; J Thariat; C Linassier; F Bertucci; J O Bay; A Bellesoeur; N Penel; S Le Guellec; T Filleron; C Chevreau
Journal:  Eur J Cancer       Date:  2016-01-26       Impact factor: 9.162

10.  Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomes.

Authors:  D K Woolf; M Williams; C L Goh; D R Henderson; R V Menashy; N Simpson; B Mastroianni; C H Collis
Journal:  Clin Oncol (R Coll Radiol)       Date:  2013-08-22       Impact factor: 4.126
View more
  1 in total

Review 1.  Transition of a vestibular schwannoma to a malignant peripheral nerve sheath tumor with loss of H3K27 trimethylation after radiosurgery-a case report and review of the literature.

Authors:  Felix Behling; Imane Bersali; Antonio Santacroce; Johann Hempel; Kosmas Kandilaris; Jens Schittenhelm; Marcos Tatagiba
Journal:  Neurosurg Rev       Date:  2021-08-15       Impact factor: 2.800
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.